临床和分子肝病学 SCIE

期刊简介预计审稿时间： 10 Weeks

Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English. Clin Mol Hepatol aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, Clin Mol Hepatol gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.

《临床与分子肝病学》（Clin Mol Hepatol）是一本国际性、同行评议、开放获取的英文期刊，每季度出版一次。《临床与分子肝病学》旨在分享肝胆疾病的先进和最新知识、趋势和理解，为临床医生、转化研究人员和基础科学家提供一个广阔的开放学术论坛，供他们进行积极的辩论和讨论，并通过多学科方法改善公共卫生，特别是在资源有限的、乙型病毒感染和肝细胞癌患病率高的亚太地区。此外，《临床与分子肝病学》优先开展东亚、北亚、东南亚、中亚、南亚、西南亚、太平洋、非洲、中欧、东欧、中美洲和南美洲的肝胆疾病流行病学研究。

《Clinical And Molecular Hepatology》(临床和分子肝病学)编辑部通讯方式为RM A1210, 53 MAPO-DAERO, MAPOTRAPALACE, DOWHA-DONG, MAPO-GU, SEOUL, SOUTH KOREA, 04158。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。